On the other hand, the specific expression of ROR1 in lung ADC tissues made it a potential target for lung ADC therapy, thus we are currently developing novel small-molecule agents and monoclonal antibodies against ROR1 to treat lung ADC patients. The gene discussed is ROR1; the disease is AIDS dementia complex.